USCIS received enough petitions to meet the H-2B statutory cap for the second half of fiscal year 2025. (Bloomberg) U.S. Citizenship and Immigration Services (USCIS) has received enough petitions ...

SEATTLE (AP) — The Seattle Mariners placed second baseman Ryan Bliss on the 10-day injured list Wednesday with a left biceps tear. The 25-year-old Bliss was injured on a swing during the ...

WASHINGTON — President Trump suggested Tuesday that Harvard University should lose its tax-exempt status — one day after his administration froze $2.2 billion in multiyear federal grants over ...

Merck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui Pharmaceuticals to jointly develop and commercialize an experimental heart disease ...

Seattle Mariners second baseman Ryan Bliss landed on the 10-day injured list Wednesday with a left biceps tear. Bliss, 25, is batting .200 with one homer, three RBIs and two stolen bases in 11 ...

We recently published a list of 30 Best AI Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Arista Networks, Inc. (NYSE:ANET) stands against other ...

The US federal government said Tuesday it was freezing more than $2.2 billion in grants and $60 million in contracts to Harvard University after the prestigious institution said it would defy the ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma) for the latter’s investigational oral small-molecule ...

ST. LOUIS (AP) — St. Louis Cardinals second baseman Masyn Winn left Friday night's game against the Philadelphia Phillies due to lower back spasms. Winn played the first inning of the game, but ...

CAMBRIDGE, Mass. — In a high-stakes standoff, President Donald Trump's administration says it will freeze $2.2 billion in federal research grants for Harvard University, which is pushing back on ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by China-based The United Laboratories International Holdings Limited.